Published in Vaccine on February 01, 1991
Primary vaccine failure after 1 dose of varicella vaccine in healthy children. J Infect Dis (2008) 2.37
Preventing varicella-zoster disease. Clin Microbiol Rev (2005) 1.55
Impact of varicella vaccine on varicella-zoster virus dynamics. Clin Microbiol Rev (2010) 1.47
A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax. Clin Vaccine Immunol (2007) 1.25
Performance of a time-resolved fluorescence immunoassay for measuring varicella-zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay. Clin Vaccine Immunol (2006) 1.20
Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen. J Clin Microbiol (2006) 1.14
Perspectives on vaccines against varicella-zoster virus infections. Curr Top Microbiol Immunol (2010) 1.11
Vaccination to prevent varicella and shingles. J Clin Pathol (2001) 1.02
Evaluation of a commercial glycoprotein enzyme-linked immunosorbent assay for measuring vaccine immunity to varicella. Yonsei Med J (2014) 0.90
Successes and challenges in varicella vaccine. Ther Adv Vaccines (2014) 0.86
Seroepidemiologic survey of varicella-zoster virus in korean adults using glycoprotein enzyme immuno assay and fluorescent antibody to membrane antigen test. Ann Dermatol (2011) 0.84
Comparative study of the standard fluorescent antibody to membrane antigen (FAMA) assay and a flow cytometry-adapted FAMA assay to assess immunity to varicella-zoster virus. Clin Vaccine Immunol (2011) 0.82
Microbiology laboratory and the management of mother-child varicella-zoster virus infection. World J Virol (2016) 0.75
Against vaccine assay secrecy. Hum Vaccin Immunother (2015) 0.75
Vaccination against varicella: what's the point? Adv Exp Med Biol (2010) 0.75
A double blind, randomized, active controlled study to assess the safety, tolerability and immunogenicity of measles, mumps rubella, and varicella vaccine (MMRV) manufactured using an alternative process. Hum Vaccin Immunother (2016) 0.75
Serological Evaluation of Immunity to the Varicella-Zoster Virus Based on a Novel Competitive Enzyme-Linked Immunosorbent Assay. Sci Rep (2016) 0.75
Safety and immunogenicity of Bio Pox™, a live varicella vaccine (Oka strain) in Indian children: A comparative multicentric, randomized phase II/III clinical trial. Hum Vaccin Immunother (2017) 0.75
The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes. Nature (1981) 8.44
Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus. Proc Natl Acad Sci U S A (1981) 5.51
Dual evolutionary origin for the rat genetic sequences of Harvey murine sarcoma virus. J Virol (1980) 4.63
Nucleotide sequence of the p21 transforming protein of Harvey murine sarcoma virus. Science (1982) 3.55
Fluorescent-antibody test for cytomegalovirus macroglobulin. N Engl J Med (1968) 3.51
Human genome contains four genes homologous to transforming genes of Harvey and Kirsten murine sarcoma viruses. Proc Natl Acad Sci U S A (1982) 3.48
Internal Hydrocephalus Following Cerebral Thrombosis, in an Infant. Proc R Soc Med (1937) 3.45
Live attenuated varicella virus vaccine. Efficacy trial in healthy children. N Engl J Med (1984) 2.93
Physical, chemical and morphologic dimensions of human hepatitis A virus strain CR326 (38578). Proc Soc Exp Biol Med (1975) 2.59
Human hepatitis B vaccine from recombinant yeast. Nature (1984) 2.46
Functional organization of the Harvey murine sarcoma virus genome. J Virol (1980) 2.46
A self-sustaining ultrahigh-frequency nanoelectromechanical oscillator. Nat Nanotechnol (2008) 2.43
Specific immune adherence assay for human hepatitis A antibody application to diagnostic and epidemiologic investigations. Proc Soc Exp Biol Med (1975) 2.38
Transformation by cloned Harvey murine sarcoma virus DNA: efficiency increased by long terminal repeat DNA. Science (1980) 2.05
A Syndrome Characterized by Ectodermal Dysplasia, Polydactyly, Chondro-Dysplasia and Congenital Morbus Cordis: Report of Three Cases. Arch Dis Child (1940) 2.00
Elective liver transplantation for the treatment of classical maple syrup urine disease. Am J Transplant (2006) 2.00
Vitamin-C Deficiency and Periostitis of Both Ulnae.? Scurvy. Proc R Soc Med (1939) 1.97
The effect of insulin on growth, nitrogen excretion and respiratory metabolism. Biochem J (1931) 1.89
Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989. Pediatrics (1991) 1.86
A novel nemaline myopathy in the Amish caused by a mutation in troponin T1. Am J Hum Genet (2000) 1.84
Heteroduplex analysis of cloned rat endogenous replication-defective (30 S) retrovirus and Harvey murine sarcoma virus. Virology (1980) 1.81
Purification of a HeLa cell receptor protein for group B coxsackieviruses. J Virol (1985) 1.81
Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood (1994) 1.75
Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology (1995) 1.73
Generation of BALB-MuSV and Ha-MuSC by type C virus transduction of homologous transforming genes from different species. Cell (1981) 1.73
Hepatic parenchymal perfusion defects detected with CTAP: imaging-pathologic correlation. Radiology (1992) 1.70
Autophosphorylation of v-Ha-ras p21 is modulated by amino acid residue 12. Proc Natl Acad Sci U S A (1984) 1.68
Identification and sequence of the gene encoding gpIII, a major glycoprotein of varicella-zoster virus. Virology (1987) 1.66
New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products. J Virol (1986) 1.59
An autosomal recessive disorder with posterior column ataxia and retinitis pigmentosa. Neurology (1997) 1.57
Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine (1991) 1.57
Similarity of synthetic peptide from human tumor to parathyroid hormone in vivo and in vitro. Science (1987) 1.56
Vertebral artery stenting. Catheter Cardiovasc Interv (2001) 1.55
Identification and structure of the gene encoding gpII, a major glycoprotein of varicella-zoster virus. Virology (1986) 1.55
Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation. Vaccine (1995) 1.53
Morphological effects of coronary balloon angioplasty in vivo assessed by intravascular ultrasound imaging. Circulation (1992) 1.53
Amplification and rearrangement of onc genes in mammalian species. Nature (1982) 1.48
Myocardial ischemia caused by postoperative malfunction of a patent internal mammary coronary arterial graft. J Vasc Surg (1990) 1.48
Blood Transfusion at the Front (Film by Dr. Frederic Duran-Jordá, Chief of the Spanish Government Blood-transfusion Service): (Section of Surgery). Proc R Soc Med (1938) 1.47
Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes. J Virol (1984) 1.45
Rheolytic thrombectomy in the treatment of acute limb-threatening ischemia: immediate results and six-month follow-up of the multicenter AngioJet registry. Possis Peripheral AngioJet Study AngioJet Investigators. Cathet Cardiovasc Diagn (1998) 1.45
Immune response of elderly individuals to a live attenuated varicella vaccine. J Infect Dis (1992) 1.45
Infrapopliteal drug-eluting stents for chronic limb ischemia. Catheter Cardiovasc Interv (2008) 1.43
The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. J Infect Dis (1996) 1.42
SV40 recombinant molecules express the gene encoding p21 transforming protein of Harvey murine sarcoma virus. Nature (1981) 1.39
Hepatic CT enhancement: comparison of ionic and nonionic contrast agents in the same patients. Radiology (1994) 1.39
Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group. Circulation (1994) 1.39
Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy. Blood (1990) 1.38
Trigeminal Naevus and Haemangioma of Meninges. Proc R Soc Med (1932) 1.37
Mouse cells contain two distinct ras gene mRNA species that can be translated into a p21 onc protein. Mol Cell Biol (1982) 1.34
Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA. JAMA (1984) 1.33
Unusually high-level expression of a foreign gene (hepatitis B virus core antigen) in Saccharomyces cerevisiae. Gene (1986) 1.32
Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood. Proc Natl Acad Sci U S A (1988) 1.31
Use of a bacterial expression vector to map the varicella-zoster virus major glycoprotein gene, gC. J Virol (1985) 1.26
Elevated frequency and allelic heterogeneity of congenital nephrotic syndrome, Finnish type, in the old order Mennonites. Am J Hum Genet (1999) 1.25
Brain magnetic resonance imaging in suspected extrapyramidal cerebral palsy: observations in distinguishing genetic-metabolic from acquired causes. J Pediatr (1997) 1.24
Chromosome assignments of four mouse cellular homologs of sarcoma and leukemia virus oncogenes. Proc Natl Acad Sci U S A (1984) 1.23
Phagocytosis of sickle erythrocytes: immunologic and oxidative determinants of hemolytic anemia. Blood (1984) 1.23
Gene structure and mutations of glutaryl-coenzyme A dehydrogenase: impaired association of enzyme subunits that is due to an A421V substitution causes glutaric acidemia type I in the Amish. Am J Hum Genet (1996) 1.21
Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response. Pediatr Infect Dis J (1992) 1.21
Restriction endonuclease analysis of the DNA from varicella-zoster virus: stability of the DNA after passage in vitro. J Gen Virol (1981) 1.21
Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine. Pediatrics (1993) 1.21
Ichthyosis Congenita. Proc R Soc Med (1936) 1.20
Protection against papillomavirus with a polynucleotide vaccine. J Infect Dis (1996) 1.19
Acute graft-versus-host disease following unrelated donor marrow transplantation: failure of conventional therapy. Bone Marrow Transplant (1992) 1.18
Prednisone therapy for acute graft-versus-host disease: short- versus long-term treatment. A prospective randomized trial. Transplantation (1993) 1.18
Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease. Biol Blood Marrow Transplant (2001) 1.18
A solid-phase assay of solubilized HeLa cell membrane receptors for binding group B coxsackieviruses and polioviruses. Virology (1982) 1.18
Protein disulfide isomerase is essential for viability in Saccharomyces cerevisiae. Gene (1991) 1.16
Diagnosis and management of glutaric aciduria type I. J Inherit Metab Dis (1998) 1.15
Unstable angina. A comparison of angioscopic findings between diabetic and nondiabetic patients. Circulation (1995) 1.15
Varicella-zoster virus as a live vector for the expression of foreign genes. Proc Natl Acad Sci U S A (1987) 1.15
Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis. J Infect Dis (1998) 1.15
Xenopus oocyte germinal-vesicle breakdown induced by [Val12]Ras is inhibited by a cytosol-localized Ras mutant. Proc Natl Acad Sci U S A (1989) 1.15
Nucleotide sequence of the two rat cellular rasH genes. Mol Cell Biol (1986) 1.15
The metabolism of carbohydrate after starvation. Biochem J (1932) 1.14
Expression of the Epstein-Barr virus gp350/220 gene in rodent and primate cells. J Virol (1987) 1.13
Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen. J Med Virol (1990) 1.11
Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge. J Immunol (1999) 1.10
Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine. J Infect Dis (1994) 1.10
Properties of the deoxycholate-solubilized HeLa cell plasma membrane receptor for binding group B coxsackieviruses. J Virol (1985) 1.09
Urinary screening tests to detect excessive lead absorption. Br J Ind Med (1966) 1.08
Comparison of gpELISA and neutralizing antibody responses to Oka/Merck live varicella vaccine (Varivax) in children and adults. Vaccine (1997) 1.08
Identification of an Epstein-Barr virus glycoprotein which is antigenically homologous to the varicella-zoster virus glycoprotein II and the herpes simplex virus glycoprotein B. Virology (1987) 1.08
The Minnesota project: a focused approach to ambulatory quality assessment. Inquiry (1990) 1.07
Rising lung cancer death rates among black men: the importance of occupation and social class. J Natl Med Assoc (1982) 1.07
3-Methylcrotonyl-coenzyme A carboxylase deficiency in Amish/Mennonite adults identified by detection of increased acylcarnitines in blood spots of their children. J Pediatr (1998) 1.07
LTR retrotransposons and the evolution of eukaryotic enhancers. Genetica (1997) 1.06
Cognitive and adaptive functioning after liver transplantation for maple syrup urine disease: a case series. Pediatr Transplant (2010) 1.05
Osteopetrosis: (Section for the Study of Disease in Children). Proc R Soc Med (1934) 1.05
Candidate Neisseria meningitidis NspA vaccine. J Biotechnol (2000) 1.03
Nucleosomal histone protein protects DNA from iron-mediated damage. Nucleic Acids Res (1992) 1.03
Immunogenicity of Haemophilus influenzae type b conjugate vaccines in infant rhesus monkeys. Pediatr Res (1991) 1.02
Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood (1992) 1.02